Dermatoscope Market, By Product (Contact Dermatoscope, Hybrid Dermatoscope, and Noncontact Dermatoscope), By Technology (LED, Xenon, Halogen, and Ultraviolet), By Modality, By End-User, By Region and Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2023-2032
- Published date: Oct 2024
- Report ID: 16157
- Number of Pages: 351
- Format:
- keyboard_arrow_up
Quick Navigation
Report Overview
The Global Dermatoscope Market size is expected to be worth around US$ 3076.7 Million by 2022, from US$ 967.4 Million in 2032, growing at a CAGR of 12.6% during the forecast period from 2023 to 2032.
Dermatoscopy is the method by which dermatologists examine skin lesions using a tool called a dermatoscopy.
The primary drivers of the dermatoscopy market expansion are rising skin cancer awareness, rising incidence of skin cancer, improvements in technology in R&D activities, and the strong need for dermatology to improve a person’s aesthetic appearance. A dermatoscopy has a magnifier, a transparent plate, a non-polarized light source, and a liquid medium between the device & the skin, which results in the production of digital images or videos.
However, factors including the availability of substitutes like SPECT and PET and the development of biological therapies for melanoma detection may restrain the market’s expansion. During the projection period, there are anticipated to be several chances for market expansion due to the high demand for the cosmetics sector and rising rates of skin cancers such as non-melanoma and melanoma.
Key Takeaways
- In 2022, the Global Dermatoscope Market was valued at USD 967.4 Million.
- The market is projected to reach USD 3,076.7 million by 2032.
- The expected CAGR between 2023 and 2032 is 12.6%.
- Contact dermatoscopes had a market share of 37.3% in 2022.
- LED technology accounted for 42.4% of the dermatoscopes market in 2022.
- Handheld dermatoscope devices held 51.8% of the market share in 2022.
- Dermatology clinics represented 56.4% of the total revenue share in 2022.
- North America dominated the market with a revenue share of 37.0% in 2022.
- The Asia Pacific is expected to have the highest CAGR of 13.3% during the forecast period.
- Noncontact dermatoscopes had a significant market share in 2022, showcasing their increasing adoption.
Product Analysis
In 2022, contact dermatoscopes held the biggest market share with a 37.3% share. There are many of these products on the market, including ones with optical lenses, LED or halogen lamps, and rechargeable batteries as power sources. In the coming years, hybrid dermatoscopes are expected to increase at a profitable rate. These advanced both contact and noncontact dermatoscopy features can be found in medical devices.
They also combine non-polarized and polarized modes for imaging applications. A hybrid dermatoscope called the Dermlite DL200, created by the 3Gen Company, combines polarized and non-polarized illumination for improved visualization of pigment and vascular structures. Noncontact dermatoscopes had a sizable market share in 2022. These tools are modern medical gadgets that function more effectively and efficiently. Their use is expanding because they help with the early diagnosis of skin melanoma and other lesions.
Technology Analysis
Based on technology, LED held 42.4% of the market share for dermatoscopes in 2022. Additionally, it is predicted to increase at the fastest rate during the projection period. As LEDs generate less heat during illumination and reduce unintentional fatalities, this technology is being used more frequently.
These bulbs provide illumination that is also brighter than that provided by halogen and xenon bulbs. Halogen lights and xenon technology are projected to hold comparatively lesser market shares for the duration of the prediction. In medical contexts when they are used, halogens can result in fatalities because of their high heat output. Xenon lights also have many drawbacks.
Modality Analysis
Based on modality, the market is divided into Handheld, Trolley Mounted, and Headband. Among these modalities, handheld devices are expected to be the most lucrative in the global dermatoscope market, with the largest revenue share of 51.8% during the predicted period. Due to the ease of use of these products, handheld devices held the majority of the market share.
They provide improved visualization, which helps dermatologists better comprehend a variety of disorders. These instruments are lighter and provide a better viewing experience than trolley-mounted dermatoscopes. The high cost and portability of trolley-mounted equipment are seen to be a constraint on their market growth.
However, they help identify and track the number of skin conditions and lesions. These gadgets are made to quickly and easily produce photographs of the full body as well as capture the entire skin surface.
End-User Analysis
Dermatology clinics held the largest market share in 2022, accounting for 56.4% of the total revenue share. The market is divided into dermatological clinics and hospitals based on end-use. The number of people requiring care and treatment at dermatology clinics is rising as a result of the rising incidence of skin cancer and melanoma.
Dermatology clinics offer patients quick and accurate diagnoses due to the availability of modern and technologically advanced medical equipment, which leads to better treatment.
Market Key Segments
Based on Product
- Contact Dermatoscope
- Hybrid Dermatoscope
- Noncontact Dermatoscope
Based on Technology
- LED
- Xenon
- Halogen
- Ultraviolet
Based on Modality
- Handheld
- Trolley Mounted
- Headband
Based on End-User
- Dermatology Clinics
- Hospitals
Drivers
Technological advances
Advancements in technology are growing more prevalent in the dermatoscope sector. This includes the emergence of digital dermatoscopes, that provide better magnification, enhanced image quality, and more accurate diagnosis. Also, the utilization of artificial intelligence (AI) in dermatoscopes has boosted the expansion of the market.
Skin cancer awareness is increasing
As skin health awareness has grown, so have the programs & campaigns for skin cancer screening. The increased awareness about skin health has led to a rise in the number of essential tools for early detection & diagnosis of skin cancer.
The prevalence of skin cancer is expanding
Skin cancer is one of the most common types of cancer worldwide. Due to the rising frequency of skin cancer identification & detection, there is a greater need for dermatoscopes, which are utilized for the early detection & diagnosis of skin cancer.
Restraints
High Cost
The price of dermatoscopes can be a major barrier to adoption, especially in underdeveloped nations. The use of dermatoscopes is constrained by their cost, which prevents many healthcare facilities from purchasing them.
Lack of Awareness
Healthcare professionals are still unaware of the advantages of utilizing dermatoscopes to diagnose skin disorders. This might reduce the demand for products since many healthcare providers may not see the value in investing in them.
Lack of Standardization
The use of dermatoscopes has not been standardized, notably in terms of terminology and diagnostic standards. This can make it challenging for medical professionals to compare outcomes and prevent the technology from being used more widely.
Opportunities
Post-Pandemic Growth and Emerging Regional Demand
Telemedicine adoption has been accelerated by the COVID-19 pandemic and is anticipated to continue in the post-pandemic era. This is expected to drive the demand for dermatoscopes that can be used for teledermatology consultations. Market expansion is anticipated to be driven by rising consumer awareness of skin health and the value of early diagnosis and treatment of skin disorders. Consumers and healthcare professionals should anticipate a rise in demand for dermatoscopes as a result of this.
Market expansion is anticipated to be driven by rising healthcare costs worldwide, particularly in emerging nations. This is a result of the rising need for advanced medical devices, such as dermatoscopes, to raise the standard of healthcare services.
Dermatoscope demand is expected to increase in emerging areas including Latin America and Asia-Pacific, offering great growth potential for market players. In the coming years, the market expansion is anticipated to be driven by the growing emphasis on enhancing healthcare infrastructure and rising healthcare spending in these regions.
Latest Trends
Artificial Intelligence Integration
To increase the precision and efficiency of diagnosis, several dermatoscopes are being combined with AI technology. Dermatoscopic pictures may be analyzed by AI algorithms to offer a diagnosis or a differential diagnosis, which can help with the early identification and treatment of skin disorders.
Wireless and Portable Dermatoscopes
Dermatoscopes that are wireless and portable are becoming more popular since they give healthcare professionals more flexibility and convenience. These devices are portable and can be used for telemedicine consultations or transportation to remote locations.
Increased Focus on Patient Comfort
A greater emphasis on patient comfort has been placed in the design of several modern dermatoscopes, which include features like adjustable illumination, ergonomic layouts, and lower noise levels. This might increase dermatoscopy patient comfort and satisfaction.
Regional Analysis
North America dominates the market with a revenue share of 37.0% in 2022. The high prevalence of skin illnesses, which is further promoted by the existence of comprehensive medical device manufacturers, healthcare infrastructure, & economic development, is one of the main drivers of growth for the local market. Europe dominated a sizeable portion of the global market in 2022 as a result of the extensive use of technologically improved equipment for the detection of lesions, inflammatory dermatoses, and skin cancer throughout the region.
Asia Pacific is anticipated to see the highest CAGR of 13.3% over the course of the projection period because of the high prevalence of melanoma, basal cell carcinoma, squamous cell carcinoma, actinic keratosis, non-pigmented, inflammatory dermatoses skin lesions in the entire region.
Key Regions
- North America
- The US
- Canada
- Mexico
- Western Europe
- Germany
- France
- The UK
- Spain
- Italy
- Portugal
- Ireland
- Austria
- Switzerland
- Benelux
- Nordic
- Rest of Western Europe
- Eastern Europe
- Russia
- Poland
- The Czech Republic
- Greece
- Rest of Eastern Europe
- APAC
- China
- Japan
- South Korea
- India
- Australia & New Zealand
- Indonesia
- Malaysia
- Philippines
- Singapore
- Thailand
- Vietnam
- Rest of APAC
- Latin America
- Brazil
- Colombia
- Chile
- Argentina
- Costa Rica
- Rest of Latin America
- Middle East & Africa
- Algeria
- Egypt
- Israel
- Kuwait
- Nigeria
- Saudi Arabia
- South Africa
- Turkey
- United Arab Emirates
- Rest of MEA
Key Players Analysis
Strategic activities including mergers and acquisitions, new inventions, and global expansion are regularly adopted by major firms. For instance, Canfield Scientific, Inc. declared the acquisition of Medici Medical s.r.l. in December 2021. The purchase will probably result in Canfield’s marketing and customer service operations expanding.
Market Key Players
- Canfield Scientific, Inc.
- 3Gen
- FotoFinder Systems
- Optilia Instruments AB
- HEINE Optotechnik GmbH & Co. KG
- Caliber Imaging & Diagnostics, Inc.
- Firefly Global
- Illuco Corporation Ltd.
- Welch Allyn
- Bio-Therapeutic Inc.
Recent Developments
- 2023: Canfield Scientific introduced proVEOS, a high-tech dermatoscope designed for use with the iPhone Pro, featuring Apple’s Super Retina XDR display. This device allows for seamless integration with Canfield’s DermaGraphix software, providing 3D images and high clarity of skin features. This product aims to advance dermatoscopic examinations by enabling detailed skin feature analysis through an iOS app, enhancing Canfield’s offerings in dermatoscopy technology.
- September 2023: FotoFinder launched “skeen,” a cutting-edge wireless digital dermatoscope featuring cloud storage capabilities. This product is designed to transform skin and hair examinations through state-of-the-art technology and artificial intelligence (AI), enhancing the efficiency of data management and patient care in dermatology.
Report Scope
Report Features Description Market Value (2022) US$ 967.4 Million Forecast Revenue (2032) US$ 3,076.7 Million CAGR (2023-2032) 12.6% Base Year for Estimation 2022 Historic Period 2018-2022 Forecast Period 2023-2032 Report Coverage Revenue Forecast, Market Dynamics, COVID-19 Impact, Competitive Landscape, Recent Developments Segments Covered By Product (Contact Dermatoscope, Hybrid Dermatoscope, and Noncontact Dermatoscope), By Technology (LED, Xenon, Halogen, and Ultraviolet), By Modality (Handheld, Trolley Mounted, and Headband) By End-User (Dermatology Clinics and Hospitals) Regional Analysis North America – The US, Canada, & Mexico; Western Europe – Germany, France, The UK, Spain, Italy, Portugal, Ireland, Austria, Switzerland, Benelux, Nordic, & Rest of Western Europe; Eastern Europe – Russia, Poland, The Czech Republic, Greece, & Rest of Eastern Europe; APAC – China, Japan, South Korea, India, Australia & New Zealand, Indonesia, Malaysia, Philippines, Singapore, Thailand, Vietnam, & Rest of APAC; Latin America – Brazil, Colombia, Chile, Argentina, Costa Rica, & Rest of Latin America; Middle East & Africa – Algeria, Egypt, Israel, Kuwait, Nigeria, Saudi Arabia, South Africa, Turkey, United Arab Emirates, & Rest of MEA Competitive Landscape Canfield Scientific, Inc., 3Gen, FotoFinder Systems, Optilia Instruments AB, HEINE Optotechnik GmbH & Co. KG, Caliber Imaging & Diagnostics, Inc., Firefly Global, Illuco Corporation Ltd., Welch Allyn, Bio-Therapeutic Inc. Customization Scope Customization for segments, region/country-level will be provided. Moreover, additional customization can be done based on the requirements. Purchase Options We have three licenses to opt for: Single User License, Multi-User License (Up to 5 Users), Corporate Use License (Unlimited User and Printable PDF) - Canfield Scientific, Inc.
- 3Gen
- FotoFinder Systems
- Optilia Instruments AB
- HEINE Optotechnik GmbH & Co. KG
- Caliber Imaging & Diagnostics, Inc.
- Firefly Global
- Illuco Corporation Ltd.
- Welch Allyn
- Bio-Therapeutic Inc.
- settingsSettings
Our Clients
Single User $6,000 $3,999 USD / per unit save 24% | Multi User $8,000 $5,999 USD / per unit save 28% | Corporate User $10,000 $6,999 USD / per unit save 32% | |
---|---|---|---|
e-Access | |||
Report Library Access | |||
Data Set (Excel) | |||
Company Profile Library Access | |||
Interactive Dashboard | |||
Free Custumization | No | up to 10 hrs work | up to 30 hrs work |
Accessibility | 1 User | 2-5 User | Unlimited |
Analyst Support | up to 20 hrs | up to 40 hrs | up to 50 hrs |
Benefit | Up to 20% off on next purchase | Up to 25% off on next purchase | Up to 30% off on next purchase |
Buy Now ($ 3,999) | Buy Now ($ 5,999) | Buy Now ($ 6,999) |